Sanofi
E133715
Sanofi is a major French multinational pharmaceutical company known for developing prescription medicines, vaccines, and consumer healthcare products worldwide.
All labels observed (8)
| Label | Occurrences |
|---|---|
| Sanofi canonical | 6 |
| Sanofi-Aventis | 2 |
| Aventis | 1 |
| Sanofi (through subsequent mergers) | 1 |
| Sanofi (via mergers) | 1 |
| Sanofi Consumer Healthcare | 1 |
| Sanofi Pasteur | 1 |
| Sanofi Vaccines | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T1151490 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Sanofi Context triple: [CAC 40, hasComponent, Sanofi]
-
A.
Roche
Roche is a major Swiss multinational healthcare company and one of the world’s leading pharmaceutical and diagnostics firms.
-
B.
Pfizer
Pfizer is a major American multinational pharmaceutical and biotechnology corporation known for developing a wide range of prescription medicines and vaccines, including one of the first widely used COVID-19 vaccines.
-
C.
AstraZeneca
AstraZeneca is a global biopharmaceutical company known for researching, developing, and manufacturing prescription medicines across areas such as oncology, cardiovascular, respiratory, and immunology.
-
D.
Merck & Co.
Merck & Co. is a major American pharmaceutical company known for developing and producing vaccines, oncology drugs, and other innovative medicines.
-
E.
Eisai
Eisai is a Japanese pharmaceutical company known for developing treatments in neurology and oncology, including Alzheimer’s disease therapies.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Sanofi Target entity description: Sanofi is a major French multinational pharmaceutical company known for developing prescription medicines, vaccines, and consumer healthcare products worldwide.
-
A.
Roche
Roche is a major Swiss multinational healthcare company and one of the world’s leading pharmaceutical and diagnostics firms.
-
B.
Pfizer
Pfizer is a major American multinational pharmaceutical and biotechnology corporation known for developing a wide range of prescription medicines and vaccines, including one of the first widely used COVID-19 vaccines.
-
C.
AstraZeneca
AstraZeneca is a global biopharmaceutical company known for researching, developing, and manufacturing prescription medicines across areas such as oncology, cardiovascular, respiratory, and immunology.
-
D.
Merck & Co.
Merck & Co. is a major American pharmaceutical company known for developing and producing vaccines, oncology drugs, and other innovative medicines.
-
E.
Eisai
Eisai is a Japanese pharmaceutical company known for developing treatments in neurology and oncology, including Alzheimer’s disease therapies.
- F. None of above. chosen
Statements (50)
| Predicate | Object |
|---|---|
| instanceOf |
multinational corporation
ⓘ
pharmaceutical company ⓘ public company ⓘ |
| collaboratesWith |
GlaxoSmithKline
ⓘ
surface form:
GSK
Regeneron Pharmaceuticals ⓘ |
| coreBusiness |
consumer healthcare products
ⓘ
prescription medicines ⓘ vaccines ⓘ |
| country | France ⓘ |
| formerlyKnownAs |
Sanofi
self-linksurface differs
ⓘ
surface form:
Sanofi-Aventis
|
| foundedBy |
Elf Aquitaine
ⓘ
Total ⓘ |
| hasBrand |
Allegra
ⓘ
Aubagio ⓘ Tylenol ⓘ
surface form:
Doliprane
Dupixent ⓘ insulin ⓘ
surface form:
Lantus
Plavix ⓘ |
| hasDivision |
Consumer Healthcare
ⓘ
General Medicines ⓘ Sanofi self-linksurface differs ⓘ
surface form:
Sanofi Vaccines
Specialty Care ⓘ |
| headquartersLocation | Paris ⓘ |
| inception | 1973 ⓘ |
| industry |
biotechnology industry
ⓘ
consumer healthcare ⓘ healthcare industry ⓘ pharmaceutical industry ⓘ vaccine industry ⓘ |
| legalForm | société anonyme ⓘ |
| numberOfEmployees | over 90,000 ⓘ |
| productType |
biological products
ⓘ
over-the-counter medicines ⓘ pharmaceutical drugs ⓘ vaccines ⓘ |
| researchFocus |
biologics
ⓘ
immuno-oncology ⓘ vaccinology ⓘ |
| scopeOfOperations | worldwide ⓘ |
| stockExchangeListing |
Euronext
ⓘ
surface form:
Euronext Paris
|
| stockIndexMembership | CAC 40 ⓘ |
| subsidiary |
Genzyme
ⓘ
Sanofi self-linksurface differs ⓘ
surface form:
Sanofi Consumer Healthcare
Sanofi self-linksurface differs ⓘ
surface form:
Sanofi Pasteur
|
| therapeuticArea |
cardiovascular diseases
ⓘ
diabetes ⓘ immunology ⓘ oncology ⓘ rare diseases ⓘ |
| tickerSymbol | SAN ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: Sanofi Description of subject: Sanofi is a major French multinational pharmaceutical company known for developing prescription medicines, vaccines, and consumer healthcare products worldwide.
Referenced by (14)
Full triples — surface form annotated when it differs from this entity's canonical label.
this entity surface form:
Sanofi-Aventis
this entity surface form:
Sanofi Pasteur
this entity surface form:
Sanofi Consumer Healthcare
this entity surface form:
Sanofi Vaccines
this entity surface form:
Sanofi-Aventis
this entity surface form:
Sanofi (through subsequent mergers)